Show
Sort by
-
TL1A aggravates cytokine-induced acute gut inflammation and potentiates infiltration of intraepithelial natural killer cells in mice
-
New methylation biomarker panel for early diagnosis of dysplasia or cancer in high-risk inflammatory bowel disease patients
-
Reliability of measuring ileo-colonic disease activity in Crohn’s Disease by magnetic resonance enterography
-
Incidence and predictors of success of adalimumab dose escalation and de-escalation in ulcerative colitis : a real-world Belgian cohort study
-
Dietary emulsifiers directly impact the human gut microbiota increasing Its pro-inflammatory potential and ability to induce intestinal inflammation
-
Long-term outcomes with anti-TNF therapy and accelerated step-up in the prospective pediatric Belgian Crohnʼs disease registry (BELCRO)
-
Anti-TNFα treatment after surgical resection for Crohn's disease is effective despite previous pharmacodynamic failure
-
Genome-wide copy number variation scan identifies complement component C4 as novel susceptibility gene for Crohn's disease
-
Bacterial intestinal superinfections in inflammatory bowel diseases beyond Clostridum difficile
-
Pediatric IBD-unclassified is less common than previously reported : results of an 8-year audit of the EUROKIDS registry